METTL3 and hepatocellular carcinoma: Analysis of the TCGA-liver hepatocellular carcinoma (LIHC) dataset revealed that METTL3 was upregulated in HCC patients with primary tumors compared with normal tissues, and higher METTL3 levels were linked to poorer overall survival in HCC patients (Figures 2D and E).